Nagomi Kurebayashi
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Pathogenic CaV1.1 Variants Cause Hyperpolarizing Shift of Depolarization-Induced Ca2+ Release in Malignant Hyperthermia Susceptibility.
Journal: Communications biology
Published: September 01, 2025
RyR1-mediated Ca2+-induced Ca2+ release plays a negligible role in excitation-contraction coupling of normal skeletal muscle.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 21, 2025
A novel selective stabilizer of the ryanodine receptor 2 prevents stress-induced ventricular arrhythmias without impairing cardiac function.
Journal: British journal of pharmacology
Published: July 30, 2025
Development of selective RyR2 inhibitors with a pharmacophore containing a parabanic acid skeleton.
Journal: RSC medicinal chemistry
Published: February 27, 2025
Crystal structures of Ryanodine Receptor reveal dantrolene and azumolene interactions guiding inhibitor development.
Journal: Nature communications
Published: February 25, 2025
Discovery and Structure-Activity Relationship of a Ryanodine Receptor 2 Inhibitor.
Journal: Chemical & pharmaceutical bulletin
Published: April 21, 2024
An inherited life-threatening arrhythmia model established by screening randomly mutagenized mice.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 15, 2024
Dual role of the S5 segment in type 1 ryanodine receptor channel gating.
Journal: Communications biology
Published: January 22, 2024
A potent and selective cis-amide inhibitor of ryanodine receptor 2 as a candidate for cardiac arrhythmia treatment.
Journal: European journal of medicinal chemistry
Published: September 14, 2023
Carvedilol suppresses ryanodine receptor-dependent Ca2+ bursts in human neurons bearing PSEN1 variants found in early onset Alzheimer's disease.
Journal: PloS one
Published: September 07, 2023
Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring.
Journal: Molecular pharmacology
Published: May 09, 2023
Novel Calmodulin Variant p.E46K Associated With Severe Catecholaminergic Polymorphic Ventricular Tachycardia Produces Robust Arrhythmogenicity in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Journal: Circulation. Arrhythmia and electrophysiology
Published: March 03, 2023
Last Updated: 09/26/2026